Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Helicobacter pylori cell wall, membrane, and associated proteins" is a broad and imprecise designation encompassing a wide array of proteins that mediate the structure, survival, and pathogenicity of H. pylori. The cell wall consists primarily of peptidoglycan, synthesized and remodeled by enzymes such as penicillin-binding proteins (PBPs) and shape-determining cytoskeletal proteins (e.g., CcmA, MreB)[1][5][7]. A large family of outer membrane proteins (OMPs)—including porins, adhesins (BabA, SabA, OipA), and other functional/paralog groups (Hom, Hop, Hof, Hor proteins)—play critical roles in adhesion, immune modulation, nutrient uptake, and antibiotic resistance[2][4][6][8]. Some OMPs, such as BabA and SabA, directly mediate binding to host cell receptors, and the presence or alteration of certain OMPs (e.g., HomB, OipA) is associated with increased virulence and clinical outcome severity[4][2]. Collectively, these proteins constitute the primary interface between H. pylori and its host, facilitating colonization, evasion of host defenses, and pathogenesis. Therapeutic targeting of these proteins, particularly PBPs and adhesins, underlies the mechanism of antibiotics and some adjuvant therapies. However, high allelic diversity, phase variation, and redundancy present major obstacles, and no single protein or family captures the entire functional landscape described by "cell wall, membrane, and associated proteins." Thus, this target designation is overly broad and not specific; for further study or drug development, individual characterization of specific enzymes or OMPs is required[2][4][6][10].
Inhibition of cell wall synthesis (e.g., by targeting PBPs); Disruption of outer membrane protein function; Inhibition of adhesion to gastric epithelium
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori cell wall, membrane, and associated protein.